focus -WSS

focus

author：explore 2025-10-02 00:52:26 - browse：47668

Attendees at the MedTech Conference in Anaheim, California. -- health tech coverage from STAT — Attendees at the AdvaMed Conference in Anaheim, Calif., on Tuesday. Eric Thayer for STAT

ANAHEIM, Calif. — Thousands of workers in the medical device industry gathered here this week for the MedTech Conference, creating an eerie dissonance with Disneyland tourists clad in Mickey Mouse ears and fanny packs.

Device makers and analysts at the conference, hosted by device lobby AdvaMed, came together to discuss medical technology’s innovation problem, the industry’s deepening relationship with the Food and Drug Administration, and the growing opportunities in digital health.

After a couple of years of tremendous gains generated by the pandemic’s demand for medical equipment, the medical device industry has hit a slump. In its annual medtech report, EY reported a 30% decline in all industry financing, which includes a drop in initial public offerings, special-purpose acquisition company deals, and venture capital funding.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： What AAP's gender

Wikipedia

hotspot

WSS

How Long Island became the ‘eugenics capital of the world’

Astellas still sees hope in its gene therapy after four deaths

Diversity in medical illustrations gets boost from Chidiebere Ibe

FDA panel gives mixed vote on blood pressure devices

Readout Newsletter: What is Casgevy? Does Wegovy hurt muscle?

CRISPR pioneers react to Casgevy, first gene

focus

focus

explore

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Psilocybin's anti

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Childhood cancer progress stalls for Black, Hispanic kids: Report

Tori Bowie and the unacceptable rates of Black maternal death

Astellas still sees hope in its gene therapy after four deaths

Medicare details structure of new drug price negotiation program

What AAP's gender

Peter Hotez and the public health issue of online harassment

Anthos stroke drug appears safer than common blood thinner

knowledge

Childhood cancer progress stalls for Black, Hispanic kids: Report

FDA's Woodcock to retire early next year

Unicorn down: Following layoffs, Biofourmis CEO quietly departs

Does good food count as health care? Study aims to find out

In science, is the line between industry and academia shifting?

David Sabatini, ex

Wikipedia

explore

hotspot

knowledge